Jaguar Health (JAGX) FCF Margin Growth (3y) (2018 - 2026)
Jaguar Health (JAGX) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
2.21 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
2.21 Mn |
| Dec 31, 2025 |
1.99 Mn |
| Sep 30, 2025 |
11,877.00 |
| Jun 30, 2025 |
15,004.00 |
| Mar 31, 2025 |
3.81 Mn |
| Dec 31, 2024 |
19,491.00 |
| Sep 30, 2024 |
129,312.00 |
| Jun 30, 2024 |
231,373.00 |
| Mar 31, 2024 |
24,127.00 |
| Dec 31, 2023 |
-28,004.00 |
| Sep 30, 2023 |
-13,562.00 |
| Jun 30, 2023 |
2.82 Mn |
| Mar 31, 2023 |
-944,412.00 |
| Dec 31, 2022 |
-1.99 Mn |
| Sep 30, 2022 |
60,756.00 |
| Jun 30, 2022 |
-4,703.00 |
| Mar 31, 2022 |
-3.83 Mn |
| Dec 31, 2021 |
-11,077.00 |
| Sep 30, 2021 |
-124,890.00 |
| Jun 30, 2021 |
-200,338.00 |
